Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.570
+0.200 (5.93%)
Jul 30, 2026, 9:55 AM EDT - Market open
Cryo-Cell International Cash Flow Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Net Income | -2.47 | -2.43 | 0.4 | -9.52 | 2.77 | 2.08 |
Depreciation & Amortization | 0.97 | 0.99 | 0.69 | 1.4 | 1.5 | 1.04 |
Stock-Based Compensation | 0.3 | 0.42 | 0.78 | 0.82 | 0.46 | 0.3 |
Other Adjustments | 2.02 | 3.67 | 0.43 | 10.24 | -0.41 | -0.35 |
Change in Receivables | -1.01 | -0.41 | -2 | -1.57 | -1.72 | 0.53 |
Changes in Inventories | 0.11 | 0.06 | 0.43 | 0.36 | 0.49 | 0.21 |
Changes in Accounts Payable | 0.61 | 1 | -0.42 | 0.69 | 0.12 | 0.53 |
Changes in Accrued Expenses | 0.29 | -1.53 | 0.64 | 1.58 | 0.53 | 0.01 |
Changes in Unearned Revenue | 4.37 | 4.36 | 5.45 | 5.3 | 4.95 | 4.25 |
Changes in Other Operating Activities | -0.42 | -0.64 | -0.4 | -0.38 | -0.12 | -0.68 |
Operating Cash Flow | 6.32 | 5.48 | 6.01 | 8.92 | 8.57 | 7.93 |
Operating Cash Flow Growth | 0.96% | -8.86% | -32.61% | 4.05% | 8.16% | -6.38% |
Capital Expenditures | -0.21 | -0.23 | -2.4 | -6.84 | -12.17 | -1.83 |
Sale of Property, Plant & Equipment | - | 0.12 | - | - | 1.87 | - |
Purchases of Intangible Assets | - | - | -1.2 | -0.8 | -5 | -5.12 |
Purchases of Investments | -1.73 | -3.65 | -2.89 | -1.08 | -1.14 | - |
Proceeds from Sale of Investments | 2.81 | 2.79 | 1.62 | 0.58 | 1.16 | - |
Investing Cash Flow | 0.87 | -0.98 | -4.88 | -8.14 | -15.28 | -6.95 |
Short-Term Debt Issued | 3.2 | 8.8 | 5.22 | 0.95 | 7.67 | - |
Short-Term Debt Repaid | -9.82 | -10.02 | -2.92 | -2 | -5.4 | - |
Net Short-Term Debt Issued (Repaid) | -6.62 | -1.22 | 2.3 | -1.05 | 2.27 | - |
Long-Term Debt Issued | - | - | - | - | 8.96 | - |
Long-Term Debt Repaid | -0.16 | -0.15 | -0.14 | -0.16 | -1.95 | -4.1 |
Net Long-Term Debt Issued (Repaid) | -0.16 | -0.15 | -0.14 | -0.16 | 7.01 | -4.1 |
Issuance of Common Stock | 0.02 | 0.02 | 0.08 | - | 0.55 | 1.28 |
Repurchase of Common Stock | -0.08 | -0.17 | -1.42 | -0.8 | -1.82 | -0.25 |
Net Common Stock Issued (Repurchased) | -0.06 | -0.15 | -1.35 | -0.8 | -1.27 | 1.03 |
Common Dividends Paid | - | -3.23 | -2.02 | - | -7.67 | - |
Other Financing Activities | - | - | 0.23 | -0.07 | -0.2 | - |
Financing Cash Flow | -6.81 | -4.75 | -0.98 | -2.07 | 0.15 | -3.07 |
Net Cash Flow | 0.37 | -0.24 | 0.15 | -1.3 | -6.56 | -2.1 |
Free Cash Flow | 6.11 | 5.25 | 3.61 | 2.08 | -3.6 | 6.09 |
Free Cash Flow Growth | 2.91% | 45.49% | 73.36% | - | - | -27.19% |
FCF Margin | 19.63% | 16.63% | 11.28% | 6.64% | -11.85% | 21.09% |
Free Cash Flow Per Share | 0.76 | 0.65 | 0.44 | 0.25 | -0.42 | 0.73 |
Levered Free Cash Flow | -3.51 | 0.2 | 6.55 | -8.61 | 7.36 | 1.51 |
Unlevered Free Cash Flow | 5.63 | 4.5 | 4.49 | -6.65 | -1.34 | 6.74 |